What is Mercy BioAnalytics worth?
$122.0Mlast known valuation
Mercy BioAnalytics last raised $27.3M in its Early Stage VC (Nov 2020).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 25 names
- ·Watchlist + deal alerts for Mercy BioAnalytics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2020 | Early Stage VC | $27.3M | ▮ | ▮ |
How Mercy BioAnalytics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Mercy BioAnalytics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Mercy BioAnalytics worth?
- Mercy BioAnalytics's last known valuation is $122.0M.
- How much has Mercy BioAnalytics raised?
- Mercy BioAnalytics has raised $127.3M in total funding across 1 recorded rounds.
- When did Mercy BioAnalytics last raise?
- Mercy BioAnalytics last raised in Nov 2020 (Early Stage VC), raising $27.3M.